Contrast Media Injectors Market

Global Contrast Media Injectors Market by Products {Injector Systems (CT Injectors, MRI Injectors, and DSA Injectors), Consumables (Syringes, Tubes, and Others), Accessories}, Injector Types (Dual-Head Injectors, Single-Head Injectors, and Syringeless Injectors), Applications (Radiology, Interventional Radiology, and Interventional Cardiology), End-Users (Hospitals, Diagnostic Centers, and Ambulatory Surgery Centers), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

  • Report ID: HC-2598
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 375
  • Format:
  • Pub. Date: 17-06-2021
  • Share:

Market Outlook:

The global contrast media injectors market was valued at USD 1,027.9 Million in 2019 and is projected to reach USD 1,589.7 Million by 2027, expanding at a CAGR of 6.8% during the forecast period. Demand for contrast media injectors is driven by the increasing demand for non-invasive and minimally invasive surgeries, growing incidence of several chronic diseases, rising research and development activities in the healthcare sector, and rising approvals for contrast agents.

Contrast media injectors are used to inject contrast media to improve the perfusion in tissues and blood. Contrast media injectors are used to inject contrast media at the time of diagnostic imaging to enhance image quality and improve patient safety. Thus, the increase in the number of cancer and CVD cases will stimulate the demand for improved healthcare facilities and advanced diagnostic imaging procedures, which, in turn, will drive the market for contrast media injectors.


Contrast Media Injectors Market key takeaways

Market Dynamics

Non-invasive and minimally invasive surgical procedures provide several advantages, such as tiny incisions instead of a large opening, quick recovery, less hospital stays, less pain, and minor surgical wounds. The use of contrast media injectors in these procedures offers high-quality real-time imaging of the surgical site and ensures the treatment of appropriate area by surgeons. Thus, the adoption of contrast media injectors for minimally invasive surgeries is increasing, which is further fueling the market.

Cases of chronic diseases requiring accurate diagnosis through different imaging systems such as computed tomography (CT) scanners and magnetic resonance imaging (MRI) equipment that requires contrast media injectors. Growing adoption of poor lifestyle is increasing incidences of chronic diseases, which is projected to drive the contrast media injectors market during the forecast period.

The contrast media injector market is expected to grow, due to the increasing expenditure on healthcare sector, and adoption of advanced diagnostics. Research and development areas of contrast media involves development of contrast media, and optimization of imaging technology for maximizing image contrast media. Moreover, the presence of various key vendors and their research and development (R&D) investments boost the growth of the market.

Rising demand for contrast agents has significantly increased over the past years, and introduction of Clariscan increases clinical offering for the US radiologists, that enhances visualization for providing better patient care. For instance, the U.S. Food and Drug Administration (FDA) has approved Clariscan is a macrocyclic, gadolinium-based, ionic, magnetic resonance imaging (MRI) contrast agent. It has been approved in more than 55 countries across the world and more than 4 Million patient doses shipped in different countries. Hence, rising number of contrast agent approvals are propelling the market.

Rivalry amongst competitors has led to high pressure on pricing strategies. Moreover, the high costs of system and side-effects of contrast agents including iodinated contrast, gadolinium, barium, and microbubble agents, is expected to limit their adoption by healthcare professionals. The cost of contrast media injectors differs, based on the types of injectors such as dual-head, single-head, and syringeless injectors. Also, cost of consumables is high as tube and syringe cannot be used again, due to hygiene and safety issues. This is a major burden for end users, thus the aforementioned factors are hampering the growth of contrast media injectors market.

Use of medical imaging as well as contrast media is expected to increase worldwide, due to rising use of computed tomography (CT), magnetic resonance imaging (MRI) and angiography procedures, and disease burdens. Rising awareness of early diagnosis of disease is expected to further drive the contrast media injectors market. Increasing awareness about patient disease diagnosis helps the population to support imaging diagnostic systems. Hence, lucrative growth opportunities in the CT scanners and MRI equipment are expected to boost the market.

Segmental Outlook

In terms of products, the contrast media injectors market is divided into injector systems, consumables, and accessories. The injector system is further divided into CT injectors, MRI injectors, and DSA injectors. The consumables segment is further segmented into syringes, tubes, and others. The consumables segment is expected to hold a significant share of the market and is projected to expand at a substantial CAGR during the forecast period, owing to rising requirement of consumables in order to maintain hygienic and safety conditions during diagnostic procedures. The CT injector sub-segment is expected to expand at a considerable CAGR, owing to the widespread application of CT injectors in cancer surgery, cardiovascular surgery, neurosurgery, and spinal procedures. Moreover, growing adoption of minimally invasive surgeries is projected to boost the demand for CT injectors during the forecast period.


Contrast Media Injectors Market by products

Based on injector types, the contrast media injectors market is categorized as dual-head injectors, single-head injectors, and syringeless injectors. The syringeless injectors segment is expected to expand at a significant pace during the forecast period, due to its advantages such as high efficiency, user-friendliness, and minimum wastage of contrast media. Moreover, leading market players of contrast media injectors are concentrating on the development of syringeless injectors, which in turn, is anticipated to drive the segment. The single-head injectors segment is expected to hold a significant share of the market and is projected to expand at a substantial CAGR during the forecast period, as it is widely used for CT, angiography, and MRI.

In terms of applications, the contrast media injectors market is segmented into radiology, interventional radiology, and interventional cardiology. The radiology segment is expected to expand at a significant pace during the forecast period, due to increasing number of radiology techniques using contrast media injectors. The growth of the segment is attributed to the diagnosis of several diseases, including breast cancer, heart conditions, broken bones, colon cancer, gastrointestinal conditions, and blood clots. The interventional cardiology segment is expected to grow at a significant pace, owing to increasing prevalence of cardiac diseases, including heart valve problems, arrhythmia, heart attacks, and strokes


In terms of end-users, the contrast media injectors market is categorized as hospitals, diagnostic centers, and Ambulatory Surgery Centers (ASCs). The hospital segment is projected to expand at a considerable pace during the forecast period, due to rising admissions of patients suffering from cardiovascular diseases, cancer, and neurological disorders. The diagnostic centers segment is expected to grow at a significant CAGR, owing to surging number of private imaging centers (driven by the increasing demand for diagnostic imaging and early diagnosis) and the absence of imaging modalities in mid-scale and small hospitals. Growing focus on the expansion of healthcare infrastructure in developing countries in Africa and Asia Pacific is anticipated to propel the hospital segment.

Regional Outlook

On the basis of regions, the global contrast media injectors market is fragmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is expected to dominate the market during the forecast period, due to factors such as growing incidence of minimally invasive procedures and rising prevalence of chronic diseases owing to changing lifestyles. The US holds significant share in the market during the forecast period, due to technological advancements in contrast media injectors devices and increasing expenditure by key players along with rising regulatory approvals. Europe region hold substantial share in the market during the forecast period, due to the local presence of various leading companies, such as Bracco Group, and others. The market in China is expected to expand at a rapid CAGR during the forecast period, due to rising disposable income and increase in funding for research and development (R&D).


Contrast Media Injectors Market by regions

Key Benefits for Industry Participants & Stakeholders

  • In-depth analysis of the global contrast media injectors market
  • Historical, current, and projected market size in terms of value (USD million) and volume (tons)
  • Potential & niche segments and regions exhibiting promising growth covered
  • Industry drivers, restraints, and opportunities covered in the study
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players

Segments

Key Segments Covered

By Products

  • Injector Systems
    • CT Injectors
    • MRI Injectors
    • DSA Injectors
  • Consumables
    • Syringes
    • Tubes
    • Others
  • Accessories

By Injector Types

  • Dual-head Injectors
  • Single-head Injectors
  • Syringeless Injectors

By Applications

  • Radiology
  • Interventional Radiology
  • Interventional Cardiology

By End-Users

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers (ASCs)

By Regions

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Market Players Profiled in the Report

  • ulrich GmbH & Co. KG
  • GENERAL ELECTRIC COMPANY
  • Bayer HealthCare LLC
  • Bracco Imaging S.p.A.
  • Guerbet
  • SINO MDT
  • APOLLO RT Co. Ltd.
  • Shenzhen Anke High-tech Co., Ltd.
  • Shenzhen Seacrown Electromechanical Co., Ltd
  • Nemoto Kyorindo Co., Ltd.
  • Smiths Group plc
  • AngioDynamics
  • MEDTRON AG

Competitive Landscape

  • Prominent manufacturers operational in the global contrast media injectors market include Bracco, Bayer AG, Guerbet, Shenzhen Anke High-tech Co., Ltd., Nemoto Kyorindo co., Ltd., Sino Medical-Device Technology Co., Ltd., and Imaxeon.
  • These companies are considered as key manufacturers of contrast media injectors based on their revenue, research & development (R&D) activities, regional presence, and supply chain management system.
Additional company profiles are provided on request.by key players

Video Summary for Contrast Media Injectors Market

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Contrast Media Injectors Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Contrast Media Injectors Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Contrast Media Injectors Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Contrast Media Injectors Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Contrast Media Injectors Market Size & Volume & Forecast, 2017-2027
      4.5.1 Contrast Media Injectors Market Size & Volume and Y-o-Y Growth
      4.5.2 Contrast Media Injectors Market Absolute $ Opportunity

   4.6 Pricing Analysis & Forecast, By Product, Region, and Country, 2017-2027
   4.7 Regulatory Requirements  
   4.8 Reimbursement Scenario
   4.9 Technological Trends & Advancements Overview  
   4.10 Business Model of Key Companies
   4.11 Installed Base By Country: CT, MRI, DSA Scanning Machines
Chapter 5 Global Contrast Media Injectors Market Analysis and Forecast By Products
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Products
      5.1.2 Basis Point Share (BPS) Analysis By Products
      5.1.3 Absolute $ Opportunity Assessment By Products
   5.2 Contrast Media Injectors Market Size & Volume Forecast By Products
      5.2.1 Injector Systems
         5.2.1.1 CT Injectors
         5.2.1.2 MRI Injectors
         5.2.1.3 DSA Injectors
      5.2.2 Consumables
         5.2.2.1 Syringes
         5.2.2.2 Tubes
         5.2.2.3 Others
      5.2.3 Accessories
   5.3 Market Attractiveness Analysis By Products
Chapter 6 Global Contrast Media Injectors Market Analysis and Forecast By Injector Types
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By Injector Types
      6.1.2 Basis Point Share (BPS) Analysis By Injector Types
      6.1.3 Absolute $ Opportunity Assessment By Injector Types
   6.2 Contrast Media Injectors Market Size & Volume Forecast By Injector Types
      6.2.1 Single-head Injectors
      6.2.2 Dual-head Injectors
      6.2.3 Syringeless Injectors
   6.3 Market Attractiveness Analysis By Injector Types
Chapter 7 Global Contrast Media Injectors Market Analysis and Forecast By Applications
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities By Applications
      7.1.2 Basis Point Share (BPS) Analysis By Applications
      7.1.3 Absolute $ Opportunity Assessment By Applications
   7.2 Contrast Media Injectors Market Size & Volume Forecast By Applications
      7.2.1 Radiology
      7.2.2 Interventional Radiology
      7.2.3 Interventional Cardiology
   7.3 Market Attractiveness Analysis By Applications
Chapter 8 Global Contrast Media Injectors Market Analysis and Forecast By End-Users
   8.1 Introduction
      8.1.1 Key Market Trends & Growth Opportunities By End-Users
      8.1.2 Basis Point Share (BPS) Analysis By End-Users
      8.1.3 Absolute $ Opportunity Assessment By End-Users
   8.2 Contrast Media Injectors Market Size & Volume Forecast By End-Users
      8.2.1 Hospitals
      8.2.2 Diagnostic Centers
      8.2.3 Ambulatory Surgery Centers (ASCs)
   8.3 Market Attractiveness Analysis By End-Users
Chapter 9 Global Contrast Media Injectors Market Analysis and Forecast by Region
   9.1 Introduction
      9.1.1 Key Market Trends & Growth Opportunities by Region
      9.1.2 Basis Point Share (BPS) Analysis by Region
      9.1.3 Absolute $ Opportunity Assessment by Region
   9.2 Contrast Media Injectors Market Size & Volume Forecast by Region
      9.2.1 North America
      9.2.2 Europe
      9.2.3 Asia Pacific
      9.2.4 Latin America
      9.2.5 Middle East & Africa (MEA)
   9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
   10.1 Introduction
   10.2 Current & Future Impact Analysis
   10.3 Economic Impact Analysis
   10.4 Government Policies
   10.5 Investment Scenario
Chapter 11 North America Contrast Media Injectors Analysis and Forecast
   11.1 Introduction
   11.2 North America Contrast Media Injectors Market Size & Volume Forecast by Country
      11.2.1 U.S.
      11.2.2 Canada
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 North America Contrast Media Injectors Market Size & Volume Forecast By Products
      11.6.1 Injector Systems
         11.6.1.1 CT Injectors
         11.6.1.2 MRI Injectors
         11.6.1.3 DSA Injectors
      11.6.2 Consumables
         11.6.2.1 Syringes
         11.6.2.2 Tubes
         11.6.2.3 Others
      11.6.3 Accessories
   11.7 Basis Point Share (BPS) Analysis By Products
   11.8 Absolute $ Opportunity Assessment By Products
   11.9 Market Attractiveness Analysis By Products
   11.10 North America Contrast Media Injectors Market Size & Volume Forecast By Injector Types
      11.10.1 Single-head Injectors
      11.10.2 Dual-head Injectors
      11.10.3 Syringeless Injectors
   11.11 Basis Point Share (BPS) Analysis By Injector Types
   11.12 Absolute $ Opportunity Assessment By Injector Types
   11.13 Market Attractiveness Analysis By Injector Types
   11.14 North America Contrast Media Injectors Market Size & Volume Forecast By Applications
      11.14.1 Radiology
      11.14.2 Interventional Radiology
      11.14.3 Interventional Cardiology
   11.15 Basis Point Share (BPS) Analysis By Applications
   11.16 Absolute $ Opportunity Assessment By Applications
   11.17 Market Attractiveness Analysis By Applications
   11.18 North America Contrast Media Injectors Market Size & Volume Forecast By End-Users
      11.18.1 Hospitals
      11.18.2 Diagnostic Centers
      11.18.3 Ambulatory Surgery Centers (ASCs)
   11.19 Basis Point Share (BPS) Analysis By End-Users
   11.20 Absolute $ Opportunity Assessment By End-Users
   11.21 Market Attractiveness Analysis By End-Users
Chapter 12 Europe Contrast Media Injectors Analysis and Forecast
   12.1 Introduction
   12.2 Europe Contrast Media Injectors Market Size & Volume Forecast by Country
      12.2.1 Germany
      12.2.2 France
      12.2.3 Italy
      12.2.4 U.K.
      12.2.5 Spain
      12.2.6 Russia
      12.2.7 Rest of Europe
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Europe Contrast Media Injectors Market Size & Volume Forecast By Products
      12.6.1 Injector Systems
         12.6.1.1 CT Injectors
         12.6.1.2 MRI Injectors
         12.6.1.3 DSA Injectors
      12.6.2 Consumables
         12.6.2.1 Syringes
         12.6.2.2 Tubes
         12.6.2.3 Others
      12.6.3 Accessories
   12.7 Basis Point Share (BPS) Analysis By Products
   12.8 Absolute $ Opportunity Assessment By Products
   12.9 Market Attractiveness Analysis By Products
   12.10 Europe Contrast Media Injectors Market Size & Volume Forecast By Injector Types
      12.10.1 Single-head Injectors
      12.10.2 Dual-head Injectors
      12.10.3 Syringeless Injectors
   12.11 Basis Point Share (BPS) Analysis By Injector Types
   12.12 Absolute $ Opportunity Assessment By Injector Types
   12.13 Market Attractiveness Analysis By Injector Types
   12.14 Europe Contrast Media Injectors Market Size & Volume Forecast By Applications
      12.14.1 Radiology
      12.14.2 Interventional Radiology
      12.14.3 Interventional Cardiology
   12.15 Basis Point Share (BPS) Analysis By Applications
   12.16 Absolute $ Opportunity Assessment By Applications
   12.17 Market Attractiveness Analysis By Applications
   12.18 Europe Contrast Media Injectors Market Size & Volume Forecast By End-Users
      12.18.1 Hospitals
      12.18.2 Diagnostic Centers
      12.18.3 Ambulatory Surgery Centers (ASCs)
   12.19 Basis Point Share (BPS) Analysis By End-Users
   12.20 Absolute $ Opportunity Assessment By End-Users
   12.21 Market Attractiveness Analysis By End-Users
Chapter 13 Asia Pacific Contrast Media Injectors Analysis and Forecast
   13.1 Introduction
   13.2 Asia Pacific Contrast Media Injectors Market Size & Volume Forecast by Country
      13.2.1 China
      13.2.2 Japan
      13.2.3 South Korea
      13.2.4 India
      13.2.5 Australia
      13.2.6 South East Asia (SEA)
      13.2.7 Rest of Asia Pacific (APAC)
      13.2.8 Indonesia
      13.2.9 Vietnam
      13.2.10 Pakistan
      13.2.11 Philippines
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Asia Pacific Contrast Media Injectors Market Size & Volume Forecast By Products
      13.6.1 Injector Systems
         13.6.1.1 CT Injectors
         13.6.1.2 MRI Injectors
         13.6.1.3 DSA Injectors
      13.6.2 Consumables
         13.6.2.1 Syringes
         13.6.2.2 Tubes
         13.6.2.3 Others
      13.6.3 Accessories
   13.7 Basis Point Share (BPS) Analysis By Products
   13.8 Absolute $ Opportunity Assessment By Products
   13.9 Market Attractiveness Analysis By Products
   13.10 Asia Pacific Contrast Media Injectors Market Size & Volume Forecast By Injector Types
      13.10.1 Single-head Injectors
      13.10.2 Dual-head Injectors
      13.10.3 Syringeless Injectors
   13.11 Basis Point Share (BPS) Analysis By Injector Types
   13.12 Absolute $ Opportunity Assessment By Injector Types
   13.13 Market Attractiveness Analysis By Injector Types
   13.14 Asia Pacific Contrast Media Injectors Market Size & Volume Forecast By Applications
      13.14.1 Radiology
      13.14.2 Interventional Radiology
      13.14.3 Interventional Cardiology
   13.15 Basis Point Share (BPS) Analysis By Applications
   13.16 Absolute $ Opportunity Assessment By Applications
   13.17 Market Attractiveness Analysis By Applications
   13.18 Asia Pacific Contrast Media Injectors Market Size & Volume Forecast By End-Users
      13.18.1 Hospitals
      13.18.2 Diagnostic Centers
      13.18.3 Ambulatory Surgery Centers (ASCs)
   13.19 Basis Point Share (BPS) Analysis By End-Users
   13.20 Absolute $ Opportunity Assessment By End-Users
   13.21 Market Attractiveness Analysis By End-Users
Chapter 14 Latin America Contrast Media Injectors Analysis and Forecast
   14.1 Introduction
   14.2 Latin America Contrast Media Injectors Market Size & Volume Forecast by Country
      14.2.1 Brazil
      14.2.2 Mexico
      14.2.3 Rest of Latin America (LATAM)
   14.3 Basis Point Share (BPS) Analysis by Country
   14.4 Absolute $ Opportunity Assessment by Country
   14.5 Market Attractiveness Analysis by Country
   14.6 Latin America Contrast Media Injectors Market Size & Volume Forecast By Products
      14.6.1 Injector Systems
         14.6.1.1 CT Injectors
         14.6.1.2 MRI Injectors
         14.6.1.3 DSA Injectors
      14.6.2 Consumables
         14.6.2.1 Syringes
         14.6.2.2 Tubes
         14.6.2.3 Others
      14.6.3 Accessories
   14.7 Basis Point Share (BPS) Analysis By Products
   14.8 Absolute $ Opportunity Assessment By Products
   14.9 Market Attractiveness Analysis By Products
   14.10 Latin America Contrast Media Injectors Market Size & Volume Forecast By Injector Types
      14.10.1 Single-head Injectors
      14.10.2 Dual-head Injectors
      14.10.3 Syringeless Injectors
   14.11 Basis Point Share (BPS) Analysis By Injector Types
   14.12 Absolute $ Opportunity Assessment By Injector Types
   14.13 Market Attractiveness Analysis By Injector Types
   14.14 Latin America Contrast Media Injectors Market Size & Volume Forecast By Applications
      14.14.1 Radiology
      14.14.2 Interventional Radiology
      14.14.3 Interventional Cardiology
   14.15 Basis Point Share (BPS) Analysis By Applications
   14.16 Absolute $ Opportunity Assessment By Applications
   14.17 Market Attractiveness Analysis By Applications
   14.18 Latin America Contrast Media Injectors Market Size & Volume Forecast By End-Users
      14.18.1 Hospitals
      14.18.2 Diagnostic Centers
      14.18.3 Ambulatory Surgery Centers (ASCs)
   14.19 Basis Point Share (BPS) Analysis By End-Users
   14.20 Absolute $ Opportunity Assessment By End-Users
   14.21 Market Attractiveness Analysis By End-Users
Chapter 15 Middle East & Africa (MEA) Contrast Media Injectors Analysis and Forecast
   15.1 Introduction
   15.2 Middle East & Africa (MEA) Contrast Media Injectors Market Size & Volume Forecast by Country
      15.2.1 Saudi Arabia
      15.2.2 South Africa
      15.2.3 UAE
      15.2.4 Rest of Middle East & Africa (MEA)
      15.2.5 Turkey
      15.2.6 Iran
      15.2.7 Iraq
   15.3 Basis Point Share (BPS) Analysis by Country
   15.4 Absolute $ Opportunity Assessment by Country
   15.5 Market Attractiveness Analysis by Country
   15.6 Middle East & Africa (MEA) Contrast Media Injectors Market Size & Volume Forecast By Products
      15.6.1 Injector Systems
         15.6.1.1 CT Injectors
         15.6.1.2 MRI Injectors
         15.6.1.3 DSA Injectors
      15.6.2 Consumables
         15.6.2.1 Syringes
         15.6.2.2 Tubes
         15.6.2.3 Others
      15.6.3 Accessories
   15.7 Basis Point Share (BPS) Analysis By Products
   15.8 Absolute $ Opportunity Assessment By Products
   15.9 Market Attractiveness Analysis By Products
   15.10 Middle East & Africa (MEA) Contrast Media Injectors Market Size & Volume Forecast By Injector Types
      15.10.1 Single-head Injectors
      15.10.2 Dual-head Injectors
      15.10.3 Syringeless Injectors
   15.11 Basis Point Share (BPS) Analysis By Injector Types
   15.12 Absolute $ Opportunity Assessment By Injector Types
   15.13 Market Attractiveness Analysis By Injector Types
   15.14 Middle East & Africa (MEA) Contrast Media Injectors Market Size & Volume Forecast By Applications
      15.14.1 Radiology
      15.14.2 Interventional Radiology
      15.14.3 Interventional Cardiology
   15.15 Basis Point Share (BPS) Analysis By Applications
   15.16 Absolute $ Opportunity Assessment By Applications
   15.17 Market Attractiveness Analysis By Applications
   15.18 Middle East & Africa (MEA) Contrast Media Injectors Market Size & Volume Forecast By End-Users
      15.18.1 Hospitals
      15.18.2 Diagnostic Centers
      15.18.3 Ambulatory Surgery Centers (ASCs)
   15.19 Basis Point Share (BPS) Analysis By End-Users
   15.20 Absolute $ Opportunity Assessment By End-Users
   15.21 Market Attractiveness Analysis By End-Users

Chapter 16 Competition Landscape
   16.1 Contrast Media Injectors Market: Competitive Dashboard
   16.2 Global Contrast Media Injectors Market: Market Share Analysis, 2019
   16.3 Company Profiles (Details - Overview, Financials, Developments, Strategy)
      16.3.1 ulrich GmbH & Co. KG
      16.3.2 GENERAL ELECTRIC COMPANY
      16.3.3 Bayer HealthCare LLC
      16.3.4 Bracco Imaging S.p.A.
      16.3.5 Guerbet
      16.3.6 SINO MDT
      16.3.7 APOLLO RT Co. Ltd.
      16.3.8 Shenzhen Anke High-tech Co., Ltd.
      16.3.9 Shenzhen Seacrown Electromechanical Co., Ltd
      16.3.10 Nemoto Kyorindo Co., Ltd.
      16.3.11 Smiths Group plc
      16.3.12 AngioDynamics
      16.3.13 MEDTRON AG
      16.3.14 Company 14
      16.3.15 Company 15

Key Segments Covered

By Products

  • Injector Systems
    • CT Injectors
    • MRI Injectors
    • DSA Injectors
  • Consumables
    • Syringes
    • Tubes
    • Others
  • Accessories

By Injector Types

  • Dual-head Injectors
  • Single-head Injectors
  • Syringeless Injectors

By Applications

  • Radiology
  • Interventional Radiology
  • Interventional Cardiology

By End-Users

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers (ASCs)

By Regions

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Market Players Profiled in the Report

  • ulrich GmbH & Co. KG
  • GENERAL ELECTRIC COMPANY
  • Bayer HealthCare LLC
  • Bracco Imaging S.p.A.
  • Guerbet
  • SINO MDT
  • APOLLO RT Co. Ltd.
  • Shenzhen Anke High-tech Co., Ltd.
  • Shenzhen Seacrown Electromechanical Co., Ltd
  • Nemoto Kyorindo Co., Ltd.
  • Smiths Group plc
  • AngioDynamics
  • MEDTRON AG
  • Prominent manufacturers operational in the global contrast media injectors market include Bracco, Bayer AG, Guerbet, Shenzhen Anke High-tech Co., Ltd., Nemoto Kyorindo co., Ltd., Sino Medical-Device Technology Co., Ltd., and Imaxeon.
  • These companies are considered as key manufacturers of contrast media injectors based on their revenue, research & development (R&D) activities, regional presence, and supply chain management system.
Additional company profiles are provided on request.by key players

Buy Report

FAQ Section

Some frequently asked quetions about this report!

Additional company profiles are provided on request.

Yes, the report provides supply chain analysis along with a list of raw material suppliers, manufacturers, distributors, and customers.

According to the Growth Market Reports, the market for contrast media injectors is likely to register a CAGR of 6.8% during forecast period 2020-2027, with an anticipated valuation of USD 1,589.7 million by the end of 2027.

In addition to market size (in USD Million) and market volume (in Thousand Units), company market share (in % for base year 2019), other data such as Pricing Analysis & Forecast, By Product, Region, and Country; Regulatory Requirements, Reimbursement Scenario, Technological Trends & Advancements Overview, Business Model of Key Companies, Installed Base By Country: CT, MRI, DSA Scanning Machines, macro-economic factors and COVID-19 impact on the value chain are available in the final report.

Applications in the global contrast media injectors market includes radiology, interventional radiology, and interventional cardiology.

Demand for contrast media injectors is expected to continue to increase over the forecast period, taking into account increasing demand for non-invasive and minimally invasive surgeries, increasing occurrence of several chronic diseases, rising research and development activities in the healthcare sector, and rising approvals for contrast agents.

Factors such as competitive strength and market positioning are key areas, which are considered while selecting top companies to be profiled.

The market is expected to decrease around 2.3% in 2020, owing to the negative impact of COVID-19 pandemic on the contrast media injectors market.

The base year considered for the global contrast media injectors market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017 & 2018 are the historic years and the forecast is provided from 2020 to 2027.

Major Manufactures are ulrich GmbH & Co. KG, GENERAL ELECTRIC COMPANY, Bayer HealthCare LLC, Bracco Imaging S.p.A., Guerbet, SINO MDT, APOLLO RT Co. Ltd.